Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ganglioside GM2 is a glycosphingolipid found in the outer leaflet of cell membranes. It plays roles in cell signaling, neuronal development, immune responses, and is implicated in lysosomal storage disorders and cancer. As a tumor-associated antigen, it is a target for cancer immunotherapy.
Antibodies targeting GM2 have shown anti-tumor effects both experimentally and clinically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ganglioside GM2.